Newron Pharmaceuticals S.p.A.
XETRA: NP5.DE0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Deutsche Börse
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Stefan Weber
- Employees
- 22
- Headquarters
- Bresso, Italy
- IPO year
- 2019
- Market cap
- €307.9M
- Website
- https://www.newron.com
Loading NP5…
Loading profile data…Frequently asked questions about NP5
What does Newron Pharmaceuticals S.p.A. (NP5.DE) do?
Newron Pharmaceuticals SpA operates as a biopharmaceutical company. The company is headquartered in Bresso, Milano and currently employs 24 full-time employees. The company focuses on the discovery and development of pharmaceutical products. The firm is engaged in discovering and developing new therapies for diseases of the Central Nervous Syste...
Where does NP5.DE trade?
Newron Pharmaceuticals S.p.A. (NP5.DE) trades on the Deutsche Börse.
What sector is NP5.DE in?
Newron Pharmaceuticals S.p.A. (NP5.DE) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Who is the CEO of Newron Pharmaceuticals S.p.A.?
Stefan Weber is the chief executive officer of Newron Pharmaceuticals S.p.A. (NP5.DE).
Where is Newron Pharmaceuticals S.p.A. headquartered?
Newron Pharmaceuticals S.p.A. is headquartered in Italy.
Does NP5.DE pay a dividend?
Newron Pharmaceuticals S.p.A. (NP5.DE) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did NP5.DE go public?
Newron Pharmaceuticals S.p.A. (NP5.DE) completed its initial public offering in 2019.